Jazz Pharmaceuticals plc 4
4 · Jazz Pharmaceuticals plc · Filed Aug 13, 2014
Insider Transaction Report
Form 4
Tobias Jeffrey K
SVP of Research & Dev and CMO
Transactions
- Exercise/Conversion
Nonstatutory Stock Option (right to buy)
2014-08-11−2,372→ 17,187 totalExercise: $59.13Exp: 2023-03-04→ Ordinary Shares (2,372 underlying) - Exercise/Conversion
Ordinary Shares
2014-08-11$59.13/sh+2,372$140,256→ 47,471 total - Exercise/Conversion
Nonstatutory Stock Option (right to buy)
2014-08-11−2,561→ 30,019 totalExercise: $46.83Exp: 2022-08-08→ Ordinary Shares (2,561 underlying) - Tax Payment
Ordinary Shares
2014-08-11$133.86/sh−4,565$611,071→ 42,538 total - Exercise/Conversion
Ordinary Shares
2014-08-11$46.83/sh+2,561$119,932→ 45,099 total - Sale
Ordinary Shares
2014-08-11$135.42/sh−4,933$668,027→ 42,538 total
Footnotes (5)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- [F2]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.12 to $135.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 20,487 shares in equal monthly installments from September 9, 2014 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.
- [F5]Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 2,603 shares and will vest with respect to 2,084 shares in equal monthly installments from September 5, 2014 to December 5, 2014 and with respect to 12,500 shares in equal monthly installments from January 5, 2015 to December 5, 2016.